PLAY PODCASTS
Rapid ART Initiation: Answering the Questions
Episode 273

Rapid ART Initiation: Answering the Questions

Hear from expert faculty as they discuss questions about rapid ART initiation for HIV, including guideline recommendations, data to support improved clinical outcomes, and rapidly transitioning from PrEP to ART after HIV seroconversion.

Decera Clinical Education Infectious Disease Podcast · Isolde Butler MD, Brenda E. Crabtree Ramírez MD

April 21, 202349m 13s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Isolde Butler, MD, and Brenda E. Crabtree Ramírez, MD, discuss rapid ART initiation for people newly diagnosed with HIV, including:

  • The HIV care continuum in the United States and Latin America
  • Barriers to HIV diagnosis, including stigma, discriminatory laws and policies, social determinants of health, and lack of access to healthcare
  • Factors that predict delayed care linkage and inconsistent HIV care and treatment
  • Improved clinical outcomes that have been shown with rapid ART initiation, first in low- and middle-income countries and now worldwide
  • Recommendations for rapid ART—and regimen choices—from the DHHS, IAS-USA, CENSIDA, EACS, and WHO
  • Recommendations for transitioning from PrEP to ART when someone seroconverts while receiving either oral PrEP or LA CAB for PrEP
  • Barriers to rapid ART initiation in their individual care settings
  • The future of LA injectable ART for initial treatment and rapid initiation

Isolde Butler, MD
Chief Medical Officer
CrescentCare
New Orleans, Louisiana

Brenda E. Crabtree Ramírez, MD
Assistant Professor, HIV Program
Department of Infectious Diseases
Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán
Mexico City, Mexico

Link to full program: bit.ly/3HPu4Lk


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

dolutegravircoinfectionstxfhigh-barrier to resistancelost to follow-upias-usacascade of carextcemtricitabine/tenofovir disoproxil fumaratedhhssame-day startlinkage to carecensidadtgsubstance userapid artxtc/txfmental healthpovertybic/ftc/taftenofovir alafenamidebictegravirantiretroviral therapydarunavirrapid initiationdrvemtricitabine/tenofovir alafenamidetransitioning from prep to arttenofovir disoproxil fumarateemtricitabineretention in caredrv/reacsdrv/rtvrapid art initiationrapid startdrv/cobihiv seroconversionstigmaemtricitabine/tenofovirdrv/cseroconversion on la cabboosted darunavirbarriers to hiv diagnosisftc/tdfhiv care continuumwhoftc/taflinkageseroconversion on prepadherencearthigh-barrier drugshiv